Novartis Ag (NVS) Inventory Average (2009 - 2026)

Novartis Ag's Inventory Average history runs 9 years deep, the most recent figure standing at $2.7 billion for Q1 2026.

• In Q1 2026, Inventory Average changed N/A year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $2.7 billion (changed N/A YoY), while the FY2025 annual figure was $6.0 billion, up 3.06% from the prior year.
• Inventory Average came in at $2.7 billion for Q1 2026 at Novartis Ag, down from $3.1 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $12.9 billion in Q3 2022 to a low of $2.7 billion in Q1 2026.
• A 4-year average of $4.7 billion and a median of $3.2 billion in 2025 frame the typical range for Inventory Average.
• On a YoY basis, Inventory Average climbed as much as 22.23% in 2023 and fell as far as 68.0% in 2023.
• Novartis Ag's Inventory Average stood at $3.8 billion in 2022, then declined by 22.23% to $3.0 billion in 2023, then gained by 5.92% to $3.1 billion in 2025, then dropped by 12.69% to $2.7 billion in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $2.7 billion, $3.1 billion, and $3.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison